Copy Number Variation in Familial Parkinson Disease

被引:59
作者
Pankratz, Nathan [1 ]
Dumitriu, Alexandra [2 ]
Hetrick, Kurt N. [3 ]
Sun, Mei [4 ,5 ]
Latourelle, Jeanne C. [2 ]
Wilk, Jemma B. [2 ]
Halter, Cheryl [1 ]
Doheny, Kimberly F. [3 ]
Gusella, James F. [4 ,6 ]
Nichols, William C. [7 ,8 ]
Myers, Richard H. [2 ]
Foroud, Tatiana [1 ]
DeStefano, Anita L. [2 ,9 ]
机构
[1] Indiana Univ Sch Med, Dept Med & Mol Genet, Indianapolis, IN 46204 USA
[2] Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA
[3] Johns Hopkins Univ, Sch Med, Inst Med Genet, CIDR, Baltimore, MD USA
[4] Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA
[5] Harvard Univ, Sch Med, Dept Neurol, Boston, MA 02115 USA
[6] Harvard Univ, Sch Med, Dept Genet, Boston, MA USA
[7] Cincinnati Childrens Hosp, Med Ctr, Div Human Genet, Cincinnati, OH USA
[8] Univ Cincinnati, Coll Med, Dept Pediat, Cincinnati, OH USA
[9] Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA USA
来源
PLOS ONE | 2011年 / 6卷 / 08期
基金
美国国家卫生研究院;
关键词
HIDDEN-MARKOV MODEL; MUTATIONS; ASSOCIATION; VARIANTS; ONSET; GENES; RARE; HETEROZYGOSITY; LINKAGE; SAMPLE;
D O I
10.1371/journal.pone.0020988
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Copy number variants (CNVs) are known to cause Mendelian forms of Parkinson disease (PD), most notably in SNCA and PARK2. PARK2 has a recessive mode of inheritance; however, recent evidence demonstrates that a single CNV in PARK2 (but not a single missense mutation) may increase risk for PD. We recently performed a genome-wide association study for PD that excluded individuals known to have either a LRRK2 mutation or two PARK2 mutations. Data from the Illumina370Duo arrays were re-clustered using only white individuals with high quality intensity data, and CNV calls were made using two algorithms, PennCNV and QuantiSNP. After quality assessment, the final sample included 816 cases and 856 controls. Results varied between the two CNV calling algorithms for many regions, including the PARK2 locus (genome-wide p = 0.04 for PennCNV and p = 0.13 for QuantiSNP). However, there was consistent evidence with both algorithms for two novel genes, USP32 and DOCK5 (empirical, genome-wide p-values<0.001). PARK2 CNVs tended to be larger, and all instances that were molecularly tested were validated. In contrast, the CNVs in both novel loci were smaller and failed to replicate using real-time PCR, MLPA, and gel electrophoresis. The DOCK5 variation is more akin to a VNTR than a typical CNV and the association is likely caused by artifact due to DNA source. DNA for all the cases was derived from whole blood, while the DNA for all controls was derived from lymphoblast cell lines. The USP32 locus contains many SNPs with low minor allele frequency leading to a loss of heterozygosity that may have been spuriously interpreted by the CNV calling algorithms as support for a deletion. Thus, only the CNVs within the PARK2 locus could be molecularly validated and associated with PD susceptibility.
引用
收藏
页数:9
相关论文
共 26 条
  • [1] QuantiSNP: an Objective Bayes Hidden-Markov Model to detect and accurately map copy number variation using SNP genotyping data
    Colella, Stefano
    Yau, Christopher
    Taylor, Jennifer M.
    Mirza, Ghazala
    Butler, Helen
    Clouston, Penny
    Bassett, Anne S.
    Seller, Anneke
    Holmes, Christopher C.
    Ragoussis, Jiannis
    [J]. NUCLEIC ACIDS RESEARCH, 2007, 35 (06) : 2013 - 2025
  • [2] Genome-wide association study of CNVs in 16,000 cases of eight common diseases and 3,000 shared controls
    Craddock, Nick
    Hurles, Matthew E.
    Cardin, Niall
    Pearson, Richard D.
    Plagnol, Vincent
    Robson, Samuel
    Vukcevic, Damjan
    Barnes, Chris
    Conrad, Donald F.
    Giannoulatou, Eleni
    Holmes, Chris
    Marchini, Jonathan L.
    Stirrups, Kathy
    Tobin, Martin D.
    Wain, Louise V.
    Yau, Chris
    Aerts, Jan
    Ahmad, Tariq
    Andrews, T. Daniel
    Arbury, Hazel
    Attwood, Anthony
    Auton, Adam
    Ball, Stephen G.
    Balmforth, Anthony J.
    Barrett, Jeffrey C.
    Barroso, Ines
    Barton, Anne
    Bennett, Amanda J.
    Bhaskar, Sanjeev
    Blaszczyk, Katarzyna
    Bowes, John
    Brand, Oliver J.
    Braund, Peter S.
    Bredin, Francesca
    Breen, Gerome
    Brown, Morris J.
    Bruce, Ian N.
    Bull, Jaswinder
    Burren, Oliver S.
    Burton, John
    Byrnes, Jake
    Caesar, Sian
    Clee, Chris M.
    Coffey, Alison J.
    Connell, John M. C.
    Cooper, Jason D.
    Dominiczak, Anna F.
    Downes, Kate
    Drummond, Hazel E.
    Dudakia, Darshna
    [J]. NATURE, 2010, 464 (7289) : 713 - U86
  • [3] Lewy bodies and parkinsonism in families with parkin mutations
    Farrer, M
    Chan, P
    Chen, R
    Tan, L
    Lincoln, S
    Hernandez, D
    Forno, L
    Gwinn-Hardy, K
    Petrucelli, L
    Hussey, J
    Singleton, A
    Tanner, C
    Hardy, J
    Langston, JW
    [J]. ANNALS OF NEUROLOGY, 2001, 50 (03) : 293 - 300
  • [4] Structural variation in the human genome
    Feuk, L
    Carson, AR
    Scherer, SW
    [J]. NATURE REVIEWS GENETICS, 2006, 7 (02) : 85 - 97
  • [5] Heterozygosity for a mutation in the parkin gene leads to later onset Parkinson disease
    Foroud, T
    Uniacke, SK
    Liu, L
    Pankratz, N
    Rudolph, A
    Halter, C
    Shults, C
    Marder, K
    Conneally, PM
    Nichols, WC
    [J]. NEUROLOGY, 2003, 60 (05) : 796 - 801
  • [6] THE RELEVANCE OF THE LEWY BODY TO THE PATHOGENESIS OF IDIOPATHIC PARKINSONS-DISEASE
    GIBB, WRG
    LEES, AJ
    [J]. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1988, 51 (06) : 745 - 752
  • [7] Whole-genome genotyping
    Gunderson, Kevin L.
    Steemers, Frank J.
    Ren, Hongi
    Ng, Pauline
    Zhou, Lixin
    Tsan, Chan
    Chang, Weihua
    Bullis, Dave
    Musmacker, Joe
    King, Christine
    Lebruska, Lori L.
    Barker, David
    Oliphant, Arnold
    Kuhn, Kenneth M.
    Shen, Richard
    [J]. DNA MICROARRAYS PART A: ARRAY PLATFORMS AND WET-BENCH PROTOCOLS, 2006, 410 : 359 - +
  • [8] Absence of previously reported variants in the SCNA (G88C and G209A), NR4A2 (T291D and T245G) and the DJ-1 (T497C) genes in familial Parkinson's disease from the GenePD study
    Karamohamed, S
    Golbe, LI
    Mark, MH
    Lazzarini, AM
    Suchowersky, O
    Labelle, N
    Guttman, M
    Currie, LJ
    Wooten, GF
    Stacy, M
    Saint-Hilaire, M
    Feldman, RG
    Liu, J
    Shoemaker, CM
    Wilk, JB
    DeStefano, AL
    Latourelle, JC
    Xu, G
    Watts, R
    Growdon, J
    Lew, M
    Waters, C
    Vieregge, P
    Pramstaller, PP
    Klein, C
    Racette, BA
    Perlmutter, JS
    Parsian, A
    Singer, C
    Montgomery, E
    Baker, K
    Gusella, JF
    Herbert, A
    Myers, RH
    [J]. MOVEMENT DISORDERS, 2005, 20 (09) : 1188 - 1191
  • [9] Klein C, 2000, ANN NEUROL, V48, P65, DOI 10.1002/1531-8249(200007)48:1<65::AID-ANA10>3.0.CO
  • [10] 2-L